142 related articles for article (PubMed ID: 35335959)
1. Hybrid Nanobeads for Oral Indomethacin Delivery.
Bonetti FMR; de Paula E; Fonseca BB; da Silva GR; da Silva LSS; de Moura LD; Breitkreitz MC; Rodrigues da Silva GH; de Morais Ribeiro LN
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335959
[TBL] [Abstract][Full Text] [Related]
2. Design of magnetic hybrid nanostructured lipid carriers containing 1,8-cineole as delivery systems for anticancer drugs: Physicochemical and cytotoxic studies.
Rodenak-Kladniew B; Noacco N; Pérez de Berti I; Stewart SJ; Cabrera AF; Alvarez VA; García de Bravo M; Durán N; Castro GR; Islan GA
Colloids Surf B Biointerfaces; 2021 Jun; 202():111710. PubMed ID: 33765626
[TBL] [Abstract][Full Text] [Related]
3. Polymer-lipid hybrid nanoparticles as enhanced indomethacin delivery systems.
Dalmoro A; Bochicchio S; Nasibullin SF; Bertoncin P; Lamberti G; Barba AA; Moustafine RI
Eur J Pharm Sci; 2018 Aug; 121():16-28. PubMed ID: 29777855
[TBL] [Abstract][Full Text] [Related]
4. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study.
Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E
Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
6. Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
Wang T; Xue J; Hu Q; Zhou M; Luo Y
J Colloid Interface Sci; 2017 Dec; 507():119-130. PubMed ID: 28780331
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains.
Ribeiro LNM; de Paula E; Rossi DA; Monteiro GP; Júnior ECV; Silva RR; Franco RR; Espíndola FS; Goulart LR; Fonseca BB
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32823823
[TBL] [Abstract][Full Text] [Related]
8. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition.
Rapalli VK; Kaul V; Waghule T; Gorantla S; Sharma S; Roy A; Dubey SK; Singhvi G
Eur J Pharm Sci; 2020 Sep; 152():105438. PubMed ID: 32598913
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
10. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
11. Functional Hybrid Nanoemulsions for Sumatriptan Intranasal Delivery.
Ribeiro LNM; Rodrigues da Silva GH; Couto VM; Castro SR; Breitkreitz MC; Martinez CS; Igartúa DE; Prieto MJ; de Paula E
Front Chem; 2020; 8():589503. PubMed ID: 33282832
[TBL] [Abstract][Full Text] [Related]
12. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
13. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.
Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X
Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283
[TBL] [Abstract][Full Text] [Related]
15. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
16. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization, cytotoxic effect and toxicity evaluation of nanostructured lipid carrier loaded with eucalyptol.
Izham MNM; Hussin Y; Rahim NFC; Aziz MNM; Yeap SK; Rahman HS; Masarudin MJ; Mohamad NE; Abdullah R; Alitheen NB
BMC Complement Med Ther; 2021 Oct; 21(1):254. PubMed ID: 34620132
[TBL] [Abstract][Full Text] [Related]
18. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.
Krambeck K; Silva V; Silva R; Fernandes C; Cagide F; Borges F; Santos D; Otero-Espinar F; Lobo JMS; Amaral MH
Int J Pharm; 2021 May; 600():120444. PubMed ID: 33713760
[TBL] [Abstract][Full Text] [Related]
19. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
Balguri SP; Adelli GR; Majumdar S
Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
